Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation

Journal of Oncology Pharmacy Practice

Volumn 19, Issue 4, 2013, Pages 291-297

  Simondsen, Katherine A ^a   Reed, Michael P ^a   Mably, Mary S ^a   Zhang, Yang ^b   Longo, Walter L ^c  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

allogeneic transplant; Fluoroquinolone; neutropenic fever; prophylaxis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; MOXIFLOXACIN; RITUXIMAB;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYCOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS INFECTION; WHOLE BODY RADIATION;

ALLOGENEIC TRANSPLANT; FLUOROQUINOLONE; NEUTROPENIC FEVER; PROPHYLAXIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; FEVER; FLUOROQUINOLONES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84888095731     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155212465215     Document Type: Article

References (8)

1. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009 ; 15: 1143-1238
2. Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transplant Infect Dis. 2005 ; 7 (1). 11-17
3. Poutsiaka DD, Price LL, Ucuzian A, et al. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007 ; 40 (1). 63-70
4. Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012 ; 1) :
5. Freifled AG, Bow EJ, Sepkowitz, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America. CID. 2011 ; 52: e56 - e93
6. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002 ; 49 (6). 999-1005
7. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005 ; 41: 1254-1260
8. Bucaneve G, Castagnola E, Viscoli C, et al. Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients. Eur J Cancer. 2007 ;: 5-12